Your browser doesn't support javascript.
loading
Estrogen Receptor-Beta2 (ERß2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).
Oturkar, Chetan C; Gandhi, Nishant; Rao, Pramod; Eng, Kevin H; Miller, Austin; Singh, Prashant K; Zsiros, Emese; Odunsi, Kunle O; Das, Gokul M.
Afiliação
  • Oturkar CC; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Gandhi N; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Rao P; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Eng KH; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Miller A; Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Singh PK; Genomic Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Zsiros E; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Odunsi KO; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Das GM; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Cancers (Basel) ; 14(5)2022 02 22.
Article em En | MEDLINE | ID: mdl-35267428
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article